Page last updated: 2024-11-02

papaverine and Premature Birth

papaverine has been researched along with Premature Birth in 2 studies

Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.

Premature Birth: CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).

Research Excerpts

ExcerptRelevanceReference
"Papaverine exposure was associated with higher rate of preterm delivery (22."5.62Pregnancy outcomes following gestational exposure to papaverine: An observational comparative study. ( Barchel, D; Berkovitch, M; Berlin, M; Braun, A; Gilan, A; Gueta, I; Kohn, E; Loebstein, R; Markovits, N, 2021)
"Papaverine exposure was associated with higher rate of preterm delivery (22."1.62Pregnancy outcomes following gestational exposure to papaverine: An observational comparative study. ( Barchel, D; Berkovitch, M; Berlin, M; Braun, A; Gilan, A; Gueta, I; Kohn, E; Loebstein, R; Markovits, N, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Rzymski, P1
Tomczyk, KM1
Wilczak, M1
Gueta, I1
Braun, A1
Gilan, A1
Berlin, M1
Kohn, E1
Barchel, D1
Markovits, N1
Berkovitch, M1
Loebstein, R1

Other Studies

2 other studies available for papaverine and Premature Birth

ArticleYear
The Influence of Oral Drotaverine Administration on Materno-Fetal Circulation during the Second and Third Trimester of Pregnancy.
    Medicina (Kaunas, Lithuania), 2022, Feb-03, Volume: 58, Issue:2

    Topics: Administration, Oral; Female; Humans; Infant, Newborn; Papaverine; Pregnancy; Pregnancy Trimester, S

2022
Pregnancy outcomes following gestational exposure to papaverine: An observational comparative study.
    British journal of clinical pharmacology, 2021, Volume: 87, Issue:10

    Topics: Cesarean Section; Female; Gestational Age; Humans; Papaverine; Pregnancy; Pregnancy Outcome; Prematu

2021